INDUSTRY

Surat's SMT begins European trial pitting its heart occluder against Abbott's Amplatzer

The Surat device maker has enrolled its first patient in a 1,260-patient European trial comparing its Cocoon occluder against Abbott's Amplatzer family, across about 60 centres.

Device maker SMT starts 1,260-patient European trial against Abbott device

Surat-based Sahajanand Medical Technologies has enrolled the first patient in SAFE-PFO, a randomised trial comparing its Cocoon patent foramen ovale occluder directly against devices from Abbott's Amplatzer family. The first enrolment was at Herz- und Diabeteszentrum NRW in Germany, under principal investigator Dr Werner Scholtz. The study plans to enrol up to 1,260 patients across about 60 European centres, with 12 months of follow-up per patient and recruitment expected to take about two years. SMT, which reported revenue of around INR 1,000 crore in FY2025 and is backed by Samara Capital, Kotak and SBI Mutual Fund, has previously filed for a public listing.

Wadi Surgicals begins domestic production of black nitrile gloves for foodservice

Production has started at about 60 lakh gloves a month, with plans to double, for a category served largely by imports. Pricing and investment were not disclosed.

Swiggy delivery partners get discounted Hero bikes and 90 percent financing

Swiggy riders can select a Hero model in the app for discounted dealership pricing, with loans at up to 90 percent of value. Neither company named the lender or the discount.

Kinetic Watts and Volts adds dealers in India

The electric two-wheeler maker has 45 showrooms operational with 40 more due within two months, and says it is assessing markets from Turkey to Nigeria. No timelines were given.

Read next